Genetron (泛生子) IPO Trading: Priced at Our Fair Value, yet There Could Be Upside
Genetron, a leading precision oncology player in China, priced at USD 16/ADS and raised USD 256 million. The stock will start trading today. In...
494 Views
Hygeia Healthcare IPO (Part II): Healthy Valuation
Hygeia Healthcare is an oncology healthcare service provider in China who operates hospitals as well as provides third-party radiotherapy services...
584 Views
Hygeia Healthcare IPO (Part I): A Better Healthcare
Hygeia Healthcare is an oncology healthcare service provider in China who operates hospitals as well as provides third-party radiotherapy services...
504 Views
Genetron (泛生子) IPO: Metrics Inferior to Burning Rock
Genetron, a China-based precision oncology company, started book building to raise up to USD 176 million to list in the US. In our previous note,...
519 Views
Genetron (泛生子) Pre-IPO: Positive Development but Tracking Behind Burning Rock
Genetron, a China-based precision oncology company, plans to raise up to USD 150 million to list in the US. In our previous note, we discussed that...
462 Views